Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01991938 |
|
Recruitment Status
:
Terminated
(Lack of recruitment and the company's decision to de-prioritize 5584 development)
First Posted
: November 25, 2013
Last Update Posted
: January 27, 2017
|
Sponsor:
Verastem, Inc.
Information provided by (Responsible Party):
Verastem, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | December 2016 |
| Actual Study Completion Date : | December 2016 |